Executive interview – Heidelberg Pharma at EKF 2019

Executive interview – Heidelberg Pharma at EKF 2019

In this interview, Dr Jan Schmidt-Brand, CEO of Heidelberg Pharma, provides an overview of the company and what differentiates its ATAC products from other ADC or CAR-Ts on the market. He also shares the company’s key partnerships and pipeline overview, the upcoming catalysts investors should pay attention to, and how the company is funded.


You may also be interested in these:

TMT

1Spatial – executive interview

TMT

MoneyHero – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free